The US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Read MoreThe US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Read MoreThe latest on our efforts to ensure accessible IVI for Australian patients.
Read MoreMDFA’s summary of the past 12 months’ research into macular disease.
Read MoreMDFA has released a new series of educational videos to help Aussies better understand macular disease.
Read MoreThe Spring 2021 Vision Voice leads with the Health Minister Greg Hunt, seeking to allay your concerns around Medicare rebate changes.
Read MoreMDFA continues to advocate against a proposal to cut Medicare rebates for eye injections and met with the Health Minister in June 2021.
Read MoreWe’re seeking to clear up any confusion around deferring eye appointments during lockdown.
Read MoreYou should seek advice from your optometrist or ophthalmologist before deferring eye appointments during lockdown.
Read MoreMDFA is delighted to officially welcome Dr James Muecke AM on board as our diabetic eye disease Ambassador.
Read More